jump to navigation

About the Barrow HH Program

Inaugurated in February of 2003, the Barrow Hypothalamic Hamartoma Program has treated over 100 children and adults with refractory seizures and hypothalamic hamartoma. For those patients in whom treatment by medication is failing, we offer surgical treatment to eradicate the hypothalamic hamartoma lesion.

The Barrow Hypothalamic Hamartoma Program is greatly indebted to Dr. Jeffrey Rosenfeld, of Melbourne, Australia, who in 2001 developed a new surgical approach to hypothalamic hamartoma (the transcallosal approach). He is a pioneering figure in the development of hypothalamic hamartoma therapy. In February 2003, Dr. Rosenfeld traveled to Barrow to teach this approach to our staff.

Since then, our team has become skilled in using this approach for treating hypothalamic hamartomas. We have also refined other surgical approaches to the hypothalamic hamartoma lesion that are more appropriate for selected patients, including the endoscopic approach and the combined approach. In addition, the traditional surgery for hypothalamic hamartoma, a subtemporal or orbitozygomatic approach, is still ideal for some patients with hypothalamic hamartoma.

To learn more about the Barrow Hypothalamic Hamartoma Program website or call 1-800-Barrow1.



No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: